Number of the records: 1
klaritromycín
SYS d017291 LBL 00000nz--a2200000o--4500 005 20250606214523.4 008 920507|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 $d BA006 065 $a D02.540.576.500.992.100 066 $a 01 $c 03 150 $a klaritromycín $x AA $x AD $x AE $x AG $x AI $x AN $x BI $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 550 $7 sllk_us_auth*d000900 $Y Anti-Bacterial Agents $w P $a antibiotiká 550 $7 sllk_us_auth*d011500 $Y Protein Synthesis Inhibitors $w P $a inhibítory proteosyntézy 550 $7 sllk_us_auth*d065692 $Y Cytochrome P-450 CYP3A Inhibitors $w P $a inhibítory cytochrómu P-450 CYP3A 665 $a 93; was CLARITHROMYCIN (NM) 1987-92 $2 eng 665 $a Erythromycin/analogs & derivatives (1987-1992) $2 eng 680 9-
$i A semisynthetic macrolide antibiotic derived from ERYTHROMYCIN that is active against a variety of microorganisms. It can inhibit PROTEIN SYNTHESIS in BACTERIA by reversibly binding to the 50S ribosomal subunits. This inhibits the translocation of aminoacyl transfer-RNA and prevents peptide chain elongation. $2 eng 750 -2
$a Clarithromycin $2 eng 980 $x M
Number of the records: 1